Dyne Therapeutics, Inc. (DYN)
NASDAQ·Healthcare·Biotechnology
$18.16
+0.64%
Mkt Cap $3.01B
Analyst Ratings
Buy
12
Hold
2
Sell
0
Price Target (29 analysts)
$37.60
Range $23.00 – $60.00
Implied Upside
+107.1%
Consensus $37.60 vs current $18.16
NASDAQ·Healthcare·Biotechnology
$18.16
+0.64%
Mkt Cap $3.01B
Buy
12
Hold
2
Sell
0
Price Target (29 analysts)
$37.60
Range $23.00 – $60.00
+107.1%
Consensus $37.60 vs current $18.16